Literature DB >> 8352345

Establishing the onset of psychotic illness.

M Beiser1, D Erickson, J A Fleming, W G Iacono.   

Abstract

OBJECTIVE: To date, the literature has provided no standardized, replicable method for establishing illness onset. The authors describe a method for dating the first appearance of prodromal signs of psychotic illness, the emergence of an acute episode, and the initiation of treatment seeking.
METHOD: Using reports by family and friends about a sample of 141 subjects with first-episode psychosis, the investigators derived a checklist of behaviors describing the evolution of various phases of illness. Supplied with the checklist, clinician pairs independently rated the critical phases in the evolution of illness: first appearance of noticeable symptoms, first appearance of prominent psychotic symptoms, and initiation of treatment seeking.
RESULTS: The judges achieved good reliability in assigning age at the first appearance of psychotic symptoms and at initiation of treatment seeking. Judging the beginning of the prodrome proved more difficult. Insidious onset proved as characteristic of affective psychosis as of schizophrenia, while treatment lag--the interval between emergence of acute psychotic symptoms and initiation of treatment seeking--was longer for schizophrenia than for affective psychosis. Onset of schizophrenia occurred earlier in women than in men. Depression with psychotic features appeared earlier in men than women.
CONCLUSIONS: Although dating the onset of illness phases is probably feasible, efforts to improve reliability must continue. The study results challenge beliefs about gender differences in age at onset.

Entities:  

Mesh:

Year:  1993        PMID: 8352345     DOI: 10.1176/ajp.150.9.1349

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  43 in total

1.  Early intervention in first-episode psychosis--the impact of a community development campaign.

Authors:  Helen Krstev; Steve Carbone; Susy M Harrigan; Christina Curry; Kathryn Elkins; Patrick D McGorry
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-09       Impact factor: 4.328

2.  Understanding the policy context for supporting students with psychiatric disabilities in higher education.

Authors:  Mary Elizabeth Collins; Carol T Mowbray
Journal:  Community Ment Health J       Date:  2005-08

Review 3.  Epidemiology of schizophrenia: review of findings and myths.

Authors:  Erick L Messias; Chuan-Yu Chen; William W Eaton
Journal:  Psychiatr Clin North Am       Date:  2007-09

4.  Anticipation or ascertainment bias in schizophrenia? Penrose's familial mental illness sample.

Authors:  A S Bassett; J Husted
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

5.  Is pre-psychotic intervention of schizophrenia realistic ?

Authors:  Mohd Razali Salleh
Journal:  Malays J Med Sci       Date:  2002-07

6.  The prodromal stage of psychotic illness: observation, detection or intervention?

Authors:  Jean Addington
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

Review 7.  Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors:  Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal:  J Child Psychol Psychiatry       Date:  2010-02-26       Impact factor: 8.982

Review 8.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Predictors of Behavioral Health Service Utilization in a Medicaid Enrolled Sample of Emerging Adults.

Authors:  Michelle Abraczinskas; Christopher Bory; Robert Plant
Journal:  Child Youth Serv Rev       Date:  2019-11-22

10.  Medication adherence for children and adolescents with first-episode psychosis following hospitalization.

Authors:  Robin E Gearing; Alice Charach
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-04-21       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.